Systems and methods for generating personalized skincare formulations based on biomarker analysis

US12406293B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-12406293-B2
Application numberUS-202218055191-A
CountryUS
Kind codeB2
Filing dateNov 14, 2022
Priority dateJul 31, 2019
Publication dateSep 2, 2025
Grant dateSep 2, 2025

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems and methods are provided for improving skincare product formulations to address predicted skin trends. A biomarker analysis system is used to determine concentrations of various protein biomarkers of a user. A skin diagnosis computing device uses the protein biomarker concentrations to determine one or more skin trends, and determines one or more skincare product ingredients to address the skin trends. A skincare product is compounded that includes the one or more skincare product ingredients.

First claim

Opening claim text (preview).

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows: 1. A non-transitory computer-readable medium having computer-executable instructions stored thereon that, in response to execution by one or more processors of one or more computing devices of a system, cause the system to perform actions for creating custom skincare products, the actions comprising: receiving, by a skin diagnosis computing device of the system, protein biomarker concentration information from an immunoassay analyzer device configured to determine protein concentrations from a sample provided by a subject by measuring fluorescence; determining, by the skin diagnosis computing device, at least one skincare product ingredient based on the protein biomarker concentration information; and transmitting, by the skin diagnosis computing device, the determined at least one skincare product ingredient to a skincare product formulation device of the system for creation of a custom skincare product. 2. The non-transitory computer-readable medium of claim 1 , wherein the actions further comprise: receiving, by the skincare product formulation device, the determined at least one skincare product ingredient; and dispensing, by the skincare product formulation device, the custom skincare product that includes the at least one skincare product ingredient. 3. The non-transitory computer-readable medium of claim 1 , wherein the actions further comprise: presenting, by the skin diagnosis computing device, a questionnaire; and receiving, by the skin diagnosis computing device, responses to questions of the questionnaire; wherein the determination of the at least one skincare product ingredient is further based on the responses. 4. The non-transitory computer-readable medium of claim 3 , wherein the questionnaire includes questions directed to at least one of climate, humidity, stress level, and smoking status. 5. The non-transitory computer-readable medium of claim 1 , wherein determining at least one skincare product ingredient includes using a recommendation engine that determines skincare product ingredients used by subjects with similar characteristics. 6. The non-transitory computer-readable medium of claim 5 , wherein the actions further comprise: receiving, by the skin diagnosis computing device, feedback on skincare products from subjects; and updating, by the skin diagnosis computing device, the recommendation engine based on the feedback. 7. A skincare product formulation device, configured to perform actions comprising: receiving, from a skin diagnosis computing device, a determined at least one skincare product ingredient, wherein the at least one skincare product ingredient is determined by the skin diagnosis computing device by performing determination actions that include: receiving, protein biomarker concentration information from an immunoassay analyzer device configured to determine protein concentrations from a sample provided by a subject by measuring fluorescence; and determining the at least one skincare product ingredient based on the protein biomarker concentration information; and dispensing the custom skincare product that includes the at least one skincare product ingredient. 8. The skincare product formulation device of claim 7 , further comprising an ingredient dispensing device, and wherein dispensing the custom skincare product that includes the at least one skincare product ingredient includes dispensing, by the ingredient dispensing device into a compounding device, the at least one skincare product ingredient from ingredient storage associated with the skincare product formulation device. 9. The skincare product formulation device of claim 8 , wherein the actions further comprise compounding, by the compounding device, a final product by performing at least one of grinding, agitating, and compacting of the at least one skincare product ingredient. 10. The skincare product formulation device of claim 7 , wherein the determination actions further include: presenting, by the skin diagnosis computing device, a questionnaire; and receiving, by the skin diagnosis computing device, responses to questions of the questionnaire; wherein the determination of the at least one skincare product ingredient is further based on the responses. 11. The skincare product formulation device of claim 10 , wherein the questionnaire includes questions directed to at least one of climate, humidity, stress level, and smoking status. 12. The skincare product formulation device of claim 7 , wherein determining at least one skincare product ingredient includes using a recommendation engine that determines skincare product ingredients used by subjects with similar characteristics. 13. The skincare product formulation device of claim 12 , wherein the determining actions further include: receiving, by the skin diagnosis computing device, feedback on skincare products from subjects; and updating, by the skin diagnosis computing device, the recommendation engine based on the feedback. 14. A skin diagnosis computing device, comprising: at least one processor; and a non-transitory computer-readable medium having computer-executable instructions stored thereon that, in response to execution by the at least one processor, cause the skin diagnosis computing device to perform actions comprising: receiving protein biomarker concentration information from an immunoassay analyzer device configured to determine protein concentrations from a sample provided by a subject by measuring fluorescence; determining at least one skincare product ingredient based on the protein biomarker concentration information; and transmitting the determined at least one skincare product ingredient to a skincare product formulation device. 15. The skin diagnosis computing device of claim 14 , wherein the skin diagnosis computing device is a smartphone, a tablet computing device, a desktop computing device, or a laptop computing device. 16. The skin diagnosis computing device of claim 14 , wherein the actions further comprise presenting a questionnaire and receiving responses to questions of the questionnaire; and wherein the determination of the at least one skincare product ingredient is further based on the responses. 17. The skin diagnosis computing device of claim 16 , wherein the questionnaire includes questions directed to at least one of climate, humidity, stress level, and smoking status. 18. The skin diagnosis computing device of claim 14 , wherein determining at least one skincare product ingredient includes using a recommendation engine that determines skincare product ingredients used by subjects with similar characteristics. 19. The skin diagnosis computing device of claim 18 , wherein the actions further comprise: receiving feedback on skincare products from subjects; and updating the recommendation engine based on the feedback.

Assignees

Inventors

Classifications

  • Structure of the control system, e.g. common controller or multiprocessor systems, interface to servo, programmable interface controller · CPC title

  • from skin · CPC title

  • ICT programming tools or database systems specially adapted for bioinformatics · CPC title

  • Medical, chemical, biological laboratory · CPC title

  • by configuring or customising goods or services · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US12406293B2 cover?
Systems and methods are provided for improving skincare product formulations to address predicted skin trends. A biomarker analysis system is used to determine concentrations of various protein biomarkers of a user. A skin diagnosis computing device uses the protein biomarker concentrations to determine one or more skin trends, and determines one or more skincare product ingredients to address …
Who is the assignee on this patent?
Oreal
What technology area does this patent fall under?
Primary CPC classification G06Q30/0631. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Sep 02 2025 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).